Metlife (MET) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $100.27, +0.55% vs the prior close of $99.72.
- Volume 3.04M shares, 1.0x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
MET rises 0.6% to $100.27. Closed at $100.27, +0.55% vs the prior close of $99.72. Day range $98.62–$100.62, opened at $100.24.
MET daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — MET rises 0.6% to $100.27
- Closed at $100.27, +0.55% vs the prior close of $99.72. Day range $98.62–$100.62, opened at $100.24.
- Volume was 3.04M shares, 1.0x its 50-day average of 3.10M.
- Price is +3.5% vs its 50-day average ($96.85) and +18.6% vs its 200-day average ($84.52).
- 52-week range $67.33–$101.44; today's close sits at 97% of that range, 1.2% below the 52-week high.
Oct 14, 2026 — MET dips 0.9% to $99.72
- Closed at $99.72, -0.92% vs the prior close of $100.65. Day range $98.38–$99.91, opened at $99.79.
- Volume was 3.70M shares, 1.2x its 50-day average of 3.13M.
- Price is +3.0% vs its 50-day average ($96.77) and +18.1% vs its 200-day average ($84.42).
- 52-week range $67.33–$101.44; today's close sits at 95% of that range, 1.7% below the 52-week high.
Oct 13, 2026 — MET rises 0.5% to $100.65, a 52-week high
- Closed at $100.65, +0.48% vs the prior close of $100.17. Day range $99.90–$101.44, opened at $101.01.
- Volume was 3.02M shares, 1.0x its 50-day average of 3.16M.
- Price is +4.1% vs its 50-day average ($96.70) and +19.4% vs its 200-day average ($84.33).
- 52-week range $67.33–$101.44; today's close sits at 98% of that range, 0.8% below the 52-week high.
Oct 12, 2026 — MET rises 1.9% to $100.17, a 52-week high
- Closed at $100.17, +1.87% vs the prior close of $98.33. Day range $98.88–$100.18, opened at $98.97.
- Volume was 2.37M shares, 0.7x its 50-day average of 3.23M.
- Price is +3.7% vs its 50-day average ($96.61) and +18.9% vs its 200-day average ($84.23).
- 52-week range $67.33–$100.93; today's close sits at 98% of that range, 0.8% below the 52-week high.
Oct 9, 2026 — MET ends flat (-0.1%) to $98.33
- Closed at $98.33, -0.14% vs the prior close of $98.47. Day range $96.73–$99.00, opened at $98.10.
- Volume was 2.34M shares, 0.7x its 50-day average of 3.30M.
- Price is +1.9% vs its 50-day average ($96.53) and +16.9% vs its 200-day average ($84.13).
- 52-week range $67.33–$100.93; today's close sits at 92% of that range, 2.6% below the 52-week high.
Oct 8, 2026 — MET rises 2.8% to $98.47, a 1-month high
- Closed at $98.47, +2.81% vs the prior close of $95.78. Day range $95.71–$98.75, opened at $95.82.
- Volume was 3.02M shares, 0.9x its 50-day average of 3.33M.
- Price is +2.0% vs its 50-day average ($96.51) and +17.2% vs its 200-day average ($84.05).
- 52-week range $67.33–$100.93; today's close sits at 93% of that range, 2.4% below the 52-week high.
Oct 7, 2026 — MET dips 1.4% to $95.78
- Closed at $95.78, -1.42% vs the prior close of $97.16. Day range $95.42–$96.82, opened at $96.34.
- Volume was 3.18M shares, 0.9x its 50-day average of 3.37M.
- Price is -0.7% vs its 50-day average ($96.48) and +14.1% vs its 200-day average ($83.96).
- 52-week range $67.33–$100.93; today's close sits at 85% of that range, 5.1% below the 52-week high.
Oct 6, 2026 — MET ends flat (+0.3%) to $97.16, 4 up days in a row
- Closed at $97.16, +0.29% vs the prior close of $96.88. Day range $97.00–$99.06, opened at $97.19.
- Volume was 4.30M shares, 1.3x its 50-day average of 3.38M.
- Price is +0.7% vs its 50-day average ($96.51) and +15.8% vs its 200-day average ($83.89).
- 52-week range $67.33–$100.93; today's close sits at 89% of that range, 3.7% below the 52-week high.
- That makes 4 straight gains.
Oct 5, 2026 — MET rises 2.6% to $96.88, 3 up days in a row
- Closed at $96.88, +2.59% vs the prior close of $94.43. Day range $94.66–$97.39, opened at $94.84.
- Volume was 4.42M shares, 1.3x its 50-day average of 3.39M.
- Price is +0.4% vs its 50-day average ($96.47) and +15.6% vs its 200-day average ($83.82).
- 52-week range $67.33–$100.93; today's close sits at 88% of that range, 4.0% below the 52-week high.
- That makes 3 straight gains.
Oct 2, 2026 — MET ends flat (+0.1%) to $94.43
- Closed at $94.43, +0.08% vs the prior close of $94.35. Day range $93.98–$94.97, opened at $93.98.
- Volume was 2.98M shares, 0.9x its 50-day average of 3.40M.
- Price is -2.1% vs its 50-day average ($96.43) and +12.8% vs its 200-day average ($83.75).
- 52-week range $67.33–$100.93; today's close sits at 81% of that range, 6.4% below the 52-week high.
MET latest news & SEC filings
Every SEC filing by or about MET in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 6, 2026 · 144 — Notice of proposed sale (Form 144)
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Oct 5, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Johnson Jeh C. received an award of 544 shares at $94.35 (≈$51.33K) on Oct 1, 2026; now holds 10,101
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 5, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Hubbard Robert Glenn received an award of 941 shares at $94.35 (≈$88.78K) on Oct 1, 2026; now holds 109,132
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 5, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Mumenthaler Christian Stephane received an award of 544 shares at $94.35 (≈$51.33K) on Oct 1, 2026; now holds 4,018
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 5, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Harris Carla A received an award of 544 shares at $94.35 (≈$51.33K) on Oct 1, 2026; now holds 11,701
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 5, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Weinberger Mark A received an award of 544 shares on Oct 1, 2026; now holds 19,932
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 24, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Aug 28, 2026 · N-PX — Annual proxy voting record
Annual proxy voting record
Aug 17, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Aug 14, 2026 · 13F-HR — Quarterly holdings report filed by an institutional investment manager
Quarterly holdings report filed by an institutional investment manager
Aug 6, 2026 · SCHEDULE 13D/A — Update to a 13D 5%+ stake disclosure
Update to a 13D 5%+ stake disclosure
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 6, 2026 · 10-Q — Quarterly report (unaudited financial statements for the quarter)
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $724.00M (prior year $604.00M) (+19.9% vs Jun 30, 2025)
- Net income: $736.00M (prior year $729.00M) (+1.0% vs Jun 30, 2025)
- Diluted EPS: $1.09 (prior year $1.03) (+5.8% vs Jun 30, 2025)
Aug 5, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
- Item 8.01 — Reported other events the company considers important.
This is a results-day filing: the earnings press release is attached as an exhibit.
Jun 29, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Things to know before you trade MET
- Last results release: Aug 5, 2026 (8-K Item 2.02). Previous ones: May 6, 2026, Feb 4, 2026, Nov 5, 2025. Based on that rhythm, the next report is likely around Nov 4, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 0.92% (largest 2.8%). That is a relatively calm stock.
- Liquidity: about 3.34M shares (≈$334.92M) trade per day on average.
- 52-week position: $100.27 vs a range of $67.33–$101.44 (97% of the range).
- Dividends: last ex-dividend date Aug 4, 2026 ($0.593/share); 4 payments in the past 12 months.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 1 sales; latest: Marlene Debel sold 21,312 shares on Jun 1, 2026.
- Latest filings: 8-K Sep 24, 2026; 8-K Aug 17, 2026; 10-Q Aug 6, 2026.
- Share count: 635.48M shares outstanding (Jul 31, 2026), -4.4% vs a year earlier — the company has been reducing its share count.
- Listing: NYSE · industry: Life Insurance.
MET market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 100.24 | 100.62 | 98.62 | 100.27 | 3.04M |
| Oct 14, 2026 | 99.79 | 99.91 | 98.38 | 99.72 | 3.70M |
| Oct 13, 2026 | 101.01 | 101.44 | 99.90 | 100.65 | 3.02M |
| Oct 12, 2026 | 98.97 | 100.18 | 98.88 | 100.17 | 2.37M |
| Oct 9, 2026 | 98.10 | 99.00 | 96.73 | 98.33 | 2.34M |
| Oct 8, 2026 | 95.82 | 98.75 | 95.71 | 98.47 | 3.02M |
| Oct 7, 2026 | 96.34 | 96.82 | 95.42 | 95.78 | 3.18M |
| Oct 6, 2026 | 97.19 | 99.06 | 97.00 | 97.16 | 4.30M |
| Oct 5, 2026 | 94.84 | 97.39 | 94.66 | 96.88 | 4.42M |
| Oct 2, 2026 | 93.98 | 94.97 | 93.98 | 94.43 | 2.98M |
| Oct 1, 2026 | 93.71 | 94.50 | 92.21 | 94.35 | 3.69M |
| Sep 30, 2026 | 94.84 | 95.56 | 94.12 | 94.16 | 3.01M |
| Sep 29, 2026 | 95.68 | 96.33 | 94.42 | 95.20 | 2.62M |
| Sep 28, 2026 | 97.51 | 97.94 | 95.39 | 95.82 | 3.24M |
| Sep 25, 2026 | 97.54 | 98.45 | 96.67 | 97.70 | 3.63M |
| Sep 24, 2026 | 97.73 | 98.18 | 97.06 | 97.25 | 3.44M |
| Sep 23, 2026 | 95.20 | 97.67 | 95.01 | 97.20 | 2.94M |
| Sep 22, 2026 | 97.47 | 98.00 | 95.03 | 95.92 | 2.64M |
| Sep 21, 2026 | 97.44 | 97.84 | 96.54 | 96.64 | 1.93M |
| Sep 18, 2026 | 96.89 | 97.29 | 96.24 | 97.04 | 7.31M |
About Metlife
Metlife (MET) is listed on the NYSE and classified by the SEC under “Life Insurance”. Its business address is in NEW YORK, NY. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1099219.
MET board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Carlos M Gutierrez | Director | Apr 3, 2026 |
| Daniel S Glaser | Director | Sep 10, 2026 |
| Robert Glenn Hubbard | Director | Sep 10, 2026 |
| Carla A Harris | Director | Sep 10, 2026 |
| Laura J Hay | Director | Sep 10, 2026 |
| Jeh C. Johnson | Director | Sep 10, 2026 |
| William E Kennard | Director | Sep 10, 2026 |
| Michel Khalaf | President & CEO | Mar 4, 2026 |
| Diana Mckenzie | Director | Sep 10, 2026 |
| Denise M Morrison | Director | Apr 3, 2026 |
| Christian Stephane Mumenthaler | Director | Sep 10, 2026 |
| Michelle Seitz | Director | Jun 18, 2026 |
| Mark A Weinberger | Director | Jun 18, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Monica M Curtis | EVP & Chief Legal Officer | Mar 4, 2026 |
| Marlene Debel | EVP & Chief Risk Officer | Sep 2, 2026 |
| Michel Khalaf | President & CEO | Mar 4, 2026 |
| John D. Mccallion | EVP & Chief Financial Officer | Sep 2, 2026 |
| Adrienne Karen O'Neill | EVP & Chief Accounting Officer | May 4, 2026 |
| Bill Pappas | EVP, Global Tech. & Ops. | Sep 2, 2026 |
| Shurawl Sibblies | EVP & Chief HR Officer | Mar 4, 2026 |
| Ramy Tadros | President, U.S. Business | Sep 10, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jun 1, 2026 | Marlene Debel | Sale | 21,312 | $81.59 |
MET financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $2.44B | $3.38B | 4.71 | $17.09B |
| Dec 31, 2024 | $2.25B | $4.43B | 5.94 | $14.60B |
| Dec 31, 2023 | $2.23B | $1.58B | 1.81 | $13.72B |
| Dec 31, 2022 | $2.11B | $5.28B | 6.30 | $13.04B |
| Dec 31, 2021 | $2.07B | $6.86B | 7.65 | $12.35B |
Latest balance sheet: total assets $759.37B, total liabilities $731.41B, cash $19.30B (as of Jun 30, 2026).
MET earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 5, 2026 | 8-K Item 2.02 (results) | $96.26 |
| May 6, 2026 | 8-K Item 2.02 (results) | $80.16 |
| Feb 4, 2026 | 8-K Item 2.02 (results) | $78.01 |
| Nov 5, 2025 | 8-K Item 2.02 (results) | $78.68 |
| Aug 6, 2025 | 8-K Item 2.02 (results) | $75.95 |
| Apr 30, 2025 | 8-K Item 2.02 (results) | $75.37 |
| Feb 5, 2025 | 8-K Item 2.02 (results) | $85.00 |
| Oct 30, 2024 | 8-K Item 2.02 (results) | $83.18 |
| Jul 31, 2024 | 8-K Item 2.02 (results) | — |
| May 1, 2024 | 8-K Item 2.02 (results) | — |
| Jan 31, 2024 | 8-K Item 2.02 (results) | — |
| Nov 1, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Life Insurance
Jackson Financial (JXN)Corebridge Financial (CRBG)Prudential Financial (PRU)Reinsurance Group Of America (RGA)Aegon (AEG)Voya Financial (VOYA)Globe Life (GL)Lincoln National (LNC)Manulife Financial (MFC)Primerica (PRI)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on MET
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.